Pharmaceutical Product Supply – Clindamycin Phosphate Topical Solution

The contract pertains to the supply of FDA-approved Clindamycin Phosphate Topical Solution, USP in 60 mL bottles, ensuring full compliance with DLA, USP, and all applicable federal regulatory standards. The product is intended for use within the Department of Defense’s medical supply chain, with delivery requirements aligned to federal pharmaceutical procurement protocols. The solicitation is classified as a subcontract under NAICS code 325412, indicating pharmaceutical preparation manufacturing, and is managed by the Medical Supply Chain Pharm FSA under the Department of Defense. Responses are due by August 10, 2026, with the opportunity posted on August 4, 2026. There is no declared set-aside designation, meaning the contract is open to all qualified vendors regardless of business size or certification status. The place of performance and point of contact details are not specified, but all deliveries must meet stringent quality and labeling standards to ensure uniformity and safety across military medical facilities. Interested parties must adhere strictly to federal pharmaceutical supply guidelines and submit proposals through the designated DIBBS portal before the deadline.